123 related articles for article (PubMed ID: 3232212)
1. Assay of GCDFP-15 by ELISA: an available method for in vitro studies of functional differentiation in human breast cancer.
Revillion-Carette F; Hornez L; Vandewalle B; Lefebvre J
Tumori; 1988 Dec; 74(6):669-74. PubMed ID: 3232212
[TBL] [Abstract][Full Text] [Related]
2. Breast gross cystic disease protein 15 in human breast cancer in culture.
Miller WR; Shivas AA; Franchimont P; Haagensen DE
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
[TBL] [Abstract][Full Text] [Related]
3. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor and prolactin in human breast cyst fluid. Possible correlations with GCDFP-15.
Collette J; Van Cauwenberge JR; Dejardin L; Carlisi A; Jaspar JM; Franchimont P
Ann N Y Acad Sci; 1990; 586():146-57. PubMed ID: 2356996
[No Abstract] [Full Text] [Related]
5. Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally).
Collette J; Van Cauwenberge JR; Le Doussal V; Serilas M; Hustin J; Carlisi A; Dejardin L; Franchimont P
Int J Rad Appl Instrum B; 1987; 14(4):385-95. PubMed ID: 3654256
[No Abstract] [Full Text] [Related]
6. Review of GCDFP-15. An apocrine marker protein.
Haagensen DE; Dilley WG; Mazoujian G; Wells SA
Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
[No Abstract] [Full Text] [Related]
7. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal regulation of GCDFP-15 secretion in breast tumors. Study of cultured cells].
Boutteville C; Revillion F; Vandewalle B; Lefèbvre J
Bull Cancer; 1989; 76(8):805-11. PubMed ID: 2620105
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
Satoh F; Umemura S; Osamura RY
Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
[TBL] [Abstract][Full Text] [Related]
11. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women.
Petrakis NL; Lowenstein JM; Wiencke JK; Lee MM; Wrensch MR; King EB; Hilton JF; Miike R
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):573-9. PubMed ID: 8268776
[TBL] [Abstract][Full Text] [Related]
12. Breast cyst fluid proteins and breast cancer.
Zangerle PF; Spyratos F; Le Doussal V; Noel G; Hacene K; Hendrick JC; Gest J; Franchimont P
Ann N Y Acad Sci; 1986; 464():331-49. PubMed ID: 3089095
[TBL] [Abstract][Full Text] [Related]
13. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum.
Mazoujian G; Parish TH; Haagensen DE
J Histochem Cytochem; 1988 Apr; 36(4):377-82. PubMed ID: 3279111
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of gross cystic disease fluid proteins.
Mazoujian G; Haagensen DE
Ann N Y Acad Sci; 1990; 586():188-97. PubMed ID: 2357000
[No Abstract] [Full Text] [Related]
15. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
[TBL] [Abstract][Full Text] [Related]
16. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.
Dumont M; Dauvois S; Simard J; Garcia T; Schachter B; Labrie F
J Steroid Biochem; 1989; 34(1-6):397-402. PubMed ID: 2626033
[TBL] [Abstract][Full Text] [Related]
17. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
[TBL] [Abstract][Full Text] [Related]
18. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia.
Caputo E; Autiero M; Mani JC; Basmaciogullari S; Piatier-Tonneau D; Guardiola J
Int J Cancer; 1998 Sep; 78(1):76-85. PubMed ID: 9724097
[TBL] [Abstract][Full Text] [Related]
19. Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer.
Bundred NJ; Stewart HJ; Shaw DA; Forrest AP; Miller WR
Eur J Cancer; 1990; 26(11-12):1145-7. PubMed ID: 2149996
[TBL] [Abstract][Full Text] [Related]
20. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
Collette J; Hendrick JC; Jaspar JM; Franchimont P
Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
